- Home
- KROS vs UHT Comparison
KROS vs UHT Comparison
Compare KROS & UHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | UHT |
|---|---|---|
| Founded | 2015 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 584.9M | 596.5M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | KROS | UHT |
|---|---|---|
| Price | $11.71 | $40.03 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | $21.86 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 253.7K | 43.3K |
| Earning Date | 05-06-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 7.33% |
| EPS Growth | ★ 146.00 | N/A |
| EPS | ★ 2.30 | 0.36 |
| Revenue | ★ $243,864,000.00 | $99,190,000.00 |
| Revenue This Year | N/A | $2.12 |
| Revenue Next Year | $2,751.79 | $2.94 |
| P/E Ratio | ★ $5.20 | $111.89 |
| Revenue Growth | N/A | ★ 0.18 |
| 52 Week Low | $10.42 | $35.26 |
| 52 Week High | $22.55 | $44.70 |
Technical Indicators
Market Signals| Indicator | KROS | UHT |
|---|---|---|
| Relative Strength Index (RSI) | 49.83 | 38.29 |
| Support Level | $10.64 | $39.47 |
| Resistance Level | $12.65 | $41.13 |
| Average True Range (ATR) | 0.47 | 0.82 |
| MACD | 0.10 | -0.05 |
| Stochastic Oscillator | 62.41 | 16.45 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About UHT Universal Health Realty Income Trust
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.